AstraZeneca’s chief executive has discussed quitting Britain in a move that would deal a significant blow to the City of ...

The company's exit from the U.K. market would spark a major index re-weighting, given AstraZeneca is the most valuable ...

London marked the slowest first half-year for IPO volume since 1997, a grim milestone punctuated by a report that AstraZeneca ...

AstraZeneca is considering moving its stock market listing from London, where it is the exchange's most valuable company, to ...

The approval comes amid speculation that the big pharma company may switch its UK stock market listing to the US.

AstraZeneca is reportedly considering moving its stock listing from London to the US, threatening a major hit to the FTSE 100 ...

It was already a bad enough week for the Prime Minister Sir Keir Starmer and the Chancellor Rachel Reeves, what with the ...

CEO Pascal Soriot has not hidden his annoyance at taxes and regulations the pharmaceutical firm have to navigate ...

The biopharmaceutical giant AstraZeneca is considering moving their stock listing from the London Stock Exchange to the US in ...

Sky's James Sillars writes that a government, struggling for authority and prioritising economic growth, can not afford to ...

It comes amid reports that the drugs maker is considering moving its listing from the UK to the US in what would be a hammer ...